Foxo Technologies Inc（FOXO）財務資料FOXOFoxo Technologies Inc

Foxo Technologies Inc (FOXO) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Healthcare, accounting for 71.4% of total sales, equivalent to $20.00K. Another important revenue stream is Labs and Life. Understanding this composition is critical for investors evaluating how FOXO navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Foxo Technologies Inc maintains a gross margin of 39.94%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -48.80%, while the net margin is -19.58%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively FOXO converts its operational activities into shareholder value.

In the context of the broader market, FOXO competes directly with industry leaders such as WORX and AUUD. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, FOXO's gross margin of 39.94% stands against WORX's 45.53% and AUUD's -4216.30%. Such benchmarking helps identify whether Foxo Technologies Inc is trading at a premium or discount relative to its financial performance.